Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 12, 2004, Pages 1653-1657

  Henriksen, G ^a   Schottelius, M ^a   Poethko, T ^a   Hauser, A ^a   Wolf, I ^a   Schwaiger, M ^a   Wester, Hans Jürgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carbon 11; Octreotate; Octreotide; PET; Somatostatin receptor

Indexed keywords

ANISALDEHYDE; CARBON 11; OCTREOTIDE; PEPTIDE; SOMATOSTATIN RECEPTOR; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG UPTAKE; IN VIVO STUDY; INTESTINE; KIDNEY; KIDNEY CLEARANCE; LIVER; MOUSE; NONHUMAN; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR DIAGNOSIS; ANIMAL; ANTIBODY SPECIFICITY; EVALUATION; FEASIBILITY STUDY; FEMALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; NUDE MOUSE; PANCREAS TUMOR; PILOT STUDY; RAT; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

ANIMALS; CARBON RADIOISOTOPES; FEASIBILITY STUDIES; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; PEPTIDES; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SOMATOSTATIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; WOMEN;

EID: 11144224341     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1582-1     Document Type: Article

References (12)

1. 68Ga]DOTA-D-Phe1-Tyr3- Octreotide: first results in patients with meningiomas. J Nucl Med 2001;42:1053-1056.
2. 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging 2003;30:117-122.
3. Lundqvist H, Tolmachev V. Targeting peptides and positron emission tomography. Biopolymers 2002;66:381-392.
4. Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Improvement of pharmacokinetics of radio-iodinated Tyr(3)-octreotide by conjugation with carbohydrates. Bioconjug Chem 2002;13:1021-1030.
5. Wester H-J, Schottelius M, Scheidhauer K, Reubi J-C, Wolf I, Schwaiger M. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration of pharmacokinetics. Eur J Nucl Med Mol Imaging 2002;29:28-38.
6. Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, et al. Glycosylated RGD-peptides: tracer for tumor targeting and angiogenesis imaging with improved pharmacokinetics. J Nucl Med 2001;42:326-336.
7. 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys. Regul Pept 1986;16:1-13.
8. 11C labelling of a protein: concanavalin A. Int J Appl Radiat Isot 1984;35:81-83.
9. 18F-labelled RGD and octreotid analogues. J Nucl Med 2004;45:892-902.
10. 18F-labelled tracer suitable for routine clinical imaging of sstr-expressing tumors using positron emission tomography. Clin Cancer Res 2004;10:3593-606.
11. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538-546.
12. 86Y-DTPA-octreotide. Nucl Med Biol 1997;24:275-286.